Respiratory Exchange Clevleand Clinic Respiratory Institute

Dr. Trate DeVolld and Dr. Katie Rivard will explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, children, and older adults.

Thomas Gildea, MD, section head of Interventional Pulmonary and Bronchoscopy, discusses Excessive Dynamic Airways Collapse (EDAC) and Tracheobronchomalacia (TBM). He talks about breathing issues that may indicate airway collapse, as well as possible connections with asthma and COPD, long-term corticosteroid use and obesity. Dr. Gildea covers using dynamic CT as a diagnostic tool and treatment possibilities that range from using CPAP to placement of a custom 3D stent.

Dr. Hannah Wang and Dr. Christopher Attaway will explore emerging RSV testing as it pertains to understanding the capabilities and limitations of different diagnostic tests.

Immune checkpoint inhibitors have revolutionized the management of many cancers. However, adverse events and side effects on various organs, including pneumonitis in the lungs, can be caused by these therapies. This episode of Respiratory Exchange Podcast covers patient or therapy side effect risk factors, using tools such as CT scans and bronchoscopy to assist in diagnosis through exclusion and the use of steroid and non-steroids as treatment.

Welcome to a special series by Respiratory Exchange Addressing the Impact of RSV and Vaccine Hesitancy.  In this series, we explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, children and older adults.  

This episode will focus on the RSV Vaccination for Older Adults, and the importance of vaccination in preventing severe illness and hospitalization. Dr. Ronan Factora explains the risks and the benefits of the RSV vaccine while emphasizing the potential consequences of hospitalization including the loss of independence.

Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messaging, and novel approaches in antiviral treatment.